AMGN - AMGEN INC
329.82
-16.430 -4.982%
Share volume: 3,804,778
Last Updated: 05-01-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.23%
PREVIOUS CLOSE
CHG
CHG%
$346.25
-16.43
-0.05%
Summary score
60%
Profitability
73%
Dept financing
43%
Liquidity
27%
Performance
60%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 2022 - 2026
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
2.84%
Return on sales
25.8%
Return on invested capital
0%
Total debt ratio
92.41%
Debt ratio change over timeo
0%
Current Ratio
1.66%
Quick Ratio
1.33%
Cash Position Ratio
0.81%
Short-term ratios 2025 - 2026
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
3.26%
Return on sales
28.47%
Return on invested capital
0%
Total debt ratio
90.35%
Debt ratio change over timeo
0%
Current Ratio
1.25%
Quick Ratio
0.97%
Cash Position Ratio
0.42%
Last quarter ratios 2026
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
2.96%
Return on sales
30.94%
Return on invested capital
0%
Total debt ratio
90.07%
Debt ratio change over time
0%
Current Ratio
1.26%
Quick Ratio
1.01%
Cash Position Ratio
0.48%
Performance ratios (change over 4 years) 2022 - 2026
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AMGN | GILD | BIIB | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 6.81% | 8.91% | 4.29% |
| Return on assets | 2.84% | 3.26% | 2.03% | 4.18% |
| Return on sales | 25.8% | 26.74% | 21.58% | -35.41% |
| Return on invested capital | 0% | 4% | 10.25% | -18.04% |
| Profitability | 41% | 73% | 82% | 37% |
| Total debt ratio | 92.41% | 65.58% | 42.64% | 13.09% |
| Debt ratio change over time | 0% | 201.57% | 3.74% | -0.97% |
| Dept financing | 25% | 43% | 12% | 4% |
| Current Ratio | 1.25% | 1.44% | 2.74% | 0% |
| Quick Ratio | 0.97% | 1.29% | 2.07% | 0% |
| Cash Position Ratio | 0.42% | 0.57% | 1.02% | 0% |
| Liquididy | 12% | 9% | 15% | 75% |
| Short-term ratios | AMGN | GILD | BIIB | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 3.26% | 5.14% | 1.41% | 0% |
| Return on sales | 28.47% | 34.26% | 15.72% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 87% | 50% | 18% | 0% |
| Total debt ratio | 90.35% | 63.14% | 37.54% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 17% | 10% | 0% |
| Current Ratio | 1.25% | 1.44% | 2.74% | 0% |
| Quick Ratio | 0.97% | 1.29% | 2.07% | 0% |
| Cash Position Ratio | 0.42% | 0.57% | 1.02% | 0% |
| Liquididy | 33% | 43% | 75% | 0% |